{"id":"W2007554762","doi":"10.1016/j.jval.2014.03.415","title":"Have New Therapies Changed the Face of Metastatic Castrate-Resistant Prostate Cancer Treatment in Canada?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Cabazitaxel; Docetaxel; Medicine; Prostate cancer; Abiraterone acetate; Denosumab; Oncology; Internal medicine; Abiraterone; Ketoconazole; Zoledronic acid; Prednisone; Taxane; Regimen; Chemotherapy; Cancer; Androgen deprivation therapy; Androgen receptor; Breast cancer; Dermatology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002911058,0.0001976513,0.0006304128,0.001063781,0.005220799,0.005409057,0.001914544,0.002629678,0.01252257],"category_scores_gemma":[0.016561,0.0002898114,0.0007138675,0.00326002,0.003842929,0.001927969,0.001277171,0.005396238,0.0003979144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1068342,"about_ca_system_score_gemma":0.2194154,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9845306,"about_ca_topic_score_gemma":0.995231,"domain_scores_codex":[0.9952438,0.0006544185,0.0001957092,0.0002238875,0.002056213,0.001625928],"domain_scores_gemma":[0.9805161,0.001873606,0.001902192,0.0001928933,0.007423711,0.008091568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.001563711,0.0003879939,0.181367,0.001418773,0.0004081205,0.001592932,0.006006877,0.00245962,0.001038333,0.06315771,0.3905758,0.3500231],"study_design_scores_gemma":[0.0004547881,0.0003591578,0.3890427,0.003542672,0.0005516962,0.001529247,0.02585135,0.00237484,0.0009862371,0.01496796,0.5599715,0.0003679184],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.09928378,0.03379411,0.0002619473,0.8252149,0.0022649,0.00003588781,0.001734255,0.00003561533,0.03737459],"genre_scores_gemma":[0.8527985,0.03484235,0.001118455,0.0971457,0.001896883,0.00002549233,0.001011829,0.0000916713,0.01106901],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1068342,"threshold_uncertainty_score":0.7751396,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09755681097515691,"score_gpt":0.3626020282345248,"score_spread":0.2650452172593679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}